BENITEC BIOPHARMA LIMITED has not announced a capital raise, but we are collating interest in any future round. Pledge your support and we will let the company know of your interest.
1. Create Account
Complete your onboarding digitally in less than 3 minutes.
2. View Terms
View the full term sheet for the capital raise.
3. Bid for Allocation
Submit and track your bid online.
Benitec Biopharma Limited (BLT) is a biotechnology company focused on the development of treatments for chronic and life-threatening human conditions based on its patented gene-silencing technology, ddRNAi. BLT has also licensed ddRNAi technology and other patent estate to other biopharmaceutical companies. The Company's current focus has been on its hepatitis C therapeutic, TT-034. Former Names Queensland Opals NL (QOP), 30/04/2002; Benitec Limited (BLT), 24/11/2011
1201/99 Mount St, North Sydney NSW 2060, Australia